JP2022514477A5 - - Google Patents

Info

Publication number
JP2022514477A5
JP2022514477A5 JP2021532866A JP2021532866A JP2022514477A5 JP 2022514477 A5 JP2022514477 A5 JP 2022514477A5 JP 2021532866 A JP2021532866 A JP 2021532866A JP 2021532866 A JP2021532866 A JP 2021532866A JP 2022514477 A5 JP2022514477 A5 JP 2022514477A5
Authority
JP
Japan
Prior art keywords
cells
seq
amino acid
acid sequence
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021532866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022514477A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/065901 external-priority patent/WO2020123766A1/en
Publication of JP2022514477A publication Critical patent/JP2022514477A/ja
Publication of JP2022514477A5 publication Critical patent/JP2022514477A5/ja
Priority to JP2024216285A priority Critical patent/JP2025028133A/ja
Withdrawn legal-status Critical Current

Links

JP2021532866A 2018-12-13 2019-12-12 Ｐｓｃａ ｃａｒ－ｔ細胞 Withdrawn JP2022514477A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024216285A JP2025028133A (ja) 2018-12-13 2024-12-11 Ｐｓｃａ ｃａｒ－ｔ細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862779394P 2018-12-13 2018-12-13
US62/779,394 2018-12-13
PCT/US2019/065901 WO2020123766A1 (en) 2018-12-13 2019-12-12 Psca car-t cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024216285A Division JP2025028133A (ja) 2018-12-13 2024-12-11 Ｐｓｃａ ｃａｒ－ｔ細胞

Publications (2)

Publication Number Publication Date
JP2022514477A JP2022514477A (ja) 2022-02-14
JP2022514477A5 true JP2022514477A5 (https=) 2022-12-16

Family

ID=71076081

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021532866A Withdrawn JP2022514477A (ja) 2018-12-13 2019-12-12 Ｐｓｃａ ｃａｒ－ｔ細胞
JP2024216285A Pending JP2025028133A (ja) 2018-12-13 2024-12-11 Ｐｓｃａ ｃａｒ－ｔ細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024216285A Pending JP2025028133A (ja) 2018-12-13 2024-12-11 Ｐｓｃａ ｃａｒ－ｔ細胞

Country Status (7)

Country Link
US (2) US20220062338A1 (https=)
EP (1) EP3894545A4 (https=)
JP (2) JP2022514477A (https=)
CN (1) CN113423822A (https=)
AU (1) AU2019397048A1 (https=)
CA (1) CA3122421A1 (https=)
WO (1) WO2020123766A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3146533A1 (en) * 2019-05-31 2020-12-03 Argus Control Systems Ltd. Plant health monitoring apparatus and methods
US20250302763A1 (en) 2024-02-22 2025-10-02 Capstan Therapeutics, Inc. Immune engineering amplification

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595379B2 (en) * 2003-05-30 2009-09-29 Agensys, Inc. Antibodies and related molecules that bind to PSCA proteins
CN101223191B (zh) * 2005-04-14 2012-09-05 阿根西斯公司 与psca蛋白结合的抗体和相关分子
WO2009032949A2 (en) * 2007-09-04 2009-03-12 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
US10934346B2 (en) * 2014-02-14 2021-03-02 Bellicum Pharmaceuticals, Inc. Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12
AU2015312117A1 (en) * 2014-09-02 2017-03-02 Bellicum Pharmaceuticals, Inc. Costimulation of chimeric antigen receptors by Myd88 and CD40 polypeptides
US20170166877A1 (en) * 2015-12-14 2017-06-15 Bellicum Pharmaceuticals, Inc. Dual controls for therapeutic cell activation or elimination

Similar Documents

Publication Publication Date Title
US11692031B2 (en) Antibody constructs for CLDN18.2 and CD3
KR101935088B1 (ko) Ror1 암을 치료하고 전이를 저해하는데 이용을 위한 항체와 백신
CN105102479B (zh) 治疗性cd47抗体
US11384139B2 (en) Antibody targeting cell surface deposited complement protein C3d and use thereof
TW201837174A (zh) 抗ｇｐｒｃ５ｄ抗體及包含該抗體之分子
CN114685655B (zh) Pd-1结合分子及其应用
TWI788698B (zh) 抗ｐｄ-ｌ１抗體及其應用
JP6640232B2 (ja) クロストリジウム・ディフィシル感染症の治療のための、クロストリジウム・ディフィシルのトキシンａ及びトキシンｂに対する四重特異性の八量体型結合剤及び抗体
US12173081B2 (en) CD19/CD38 multispecific antibodies
JP2022514786A (ja) Ｍｕｃ１８に特異的な抗体
WO2024260440A1 (zh) 一种能够结合lilrb2的抗体或其抗原结合片段
WO2023115528A1 (en) Antibodies against mesothelin and uses thereof
JP2022514477A5 (https=)
WO2022143550A1 (zh) 间皮素结合分子及其应用
JP2022534808A5 (https=)
JP2025181917A5 (https=)
AU2020272376B2 (en) Bispecific antibody specifically binding to GPNMB and CD3, and use thereof
CA3195886A1 (en) Herv-k antibody therapeutics
US8883978B2 (en) Antibodies to tumor endothelial marker 7R
WO2018233333A9 (zh) 一种靶向人肿瘤干细胞的单克隆抗体及其应用
CN113368232B (zh) 多特异性抗原结合蛋白及其应用
US20260022165A1 (en) Antibodies targeting cell surface deposited complement protein c3d and use thereof
US20250313627A1 (en) Receptor tyrosine kinase-like orphan receptor 1 (ror1)-specific vhh antibodies and multispecific antibodies thereof as immune cell engagers
CA3107192C (en) Antibody constructs for cldn18.2 and cd3
US11518811B2 (en) Human antibody and fragments thereof for use in the treatment of gastric cancer (GC) and other types of tumours expressing the MICA protein (MHC class I chain-related protein A gene)